ArticleBioinformatics (Oxford, England)2025
Less is more: improving cell-type identification with augmentation-free single-cell RNA-Seq contrastive learning.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationCell-type identification is one of the most important tasks in single-cell RNA Sequencing (scRNA-Seq) analysis. Recent research has revealed contrastive learning's great potential in handling multiple cell-type identification tasks.
resultsIn this work, we proposed a novel augmentation-free scRNA-Seq contrastive learning (AF-RCL) algorithm, which simplifies the conventional data augmentation operation and adopts a new contrastive learning loss function. A large-scale empirical evaluation suggests that AF-RCL not only outperformed other contrastive learning-based cell-type identification methods but also obtained state-of-the-art predictive performance compared with other well-known cell-type identification methods. Further analysis also shows AF-RCL's advantages in learning high-quality discriminative feature representations based on scRNA-Seq expression profiles. AVAILABILITY AND IMPLEMENTATION: The source code is available at https://doi.org/10.6084/m9.figshare.28830311.v1 and at https://github.com/ibrahimsaggaf/AFRCL. The pre-trained AF-RCL encoders can be downloaded from https://doi.org/10.5281/zenodo.15109736, and the scRNA-Seq datasets used in this work can be downloaded from https://doi.org/10.5281/zenodo.8087611.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.